| Xcytrin (motexafin gadolinum) / AbbVie |
NCT00006452: Gadolinium Texaphyrin Plus Radiation Therapy in Treating Patients With Supratentorial Glioblastoma Multiforme |
|
|
| Completed | 1 | 6 | NA | motexafin gadolinium, radiation therapy | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, National Cancer Institute (NCI) | Brain and Central Nervous System Tumors | 05/03 | 03/04 | | |
NCT00004262: Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma Multiforme |
|
|
| Completed | 1 | 12 | US | conventional surgery, surgery, conventional, 3-dimensional conformal radiation therapy, 3D conformal radiation therapy, 3D-CRT, stereotactic radiosurgery, motexafin gadolinium, gadolinium texaphyrin, Gd (III) Texaphryin, Gd-Tex, PCI-0120, Xcytrin, magnetic resonance imaging, MRI, NMR imaging, NMRI, nuclear magnetic resonance imaging, spectroscopy | National Cancer Institute (NCI) | Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma | 05/05 | | | |
NCT00003909: Motexafin Gadolinium Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma |
|
|
| Completed | 1 | 24 | US | motexafin gadolinium, gadolinium texaphyrin, Gd (III) Texaphryin, Gd-Tex, PCI-0120, Xcytrin, radiation therapy, irradiation, radiotherapy, therapy, radiation, pharmacological study, pharmacological studies | National Cancer Institute (NCI) | Untreated Childhood Brain Stem Glioma | 03/07 | | | |
NCT00003409: Motexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
|
|
| Completed | 1 | | US | motexafin gadolinium, radiation therapy | Jonsson Comprehensive Cancer Center, National Cancer Institute (NCI) | Brain and Central Nervous System Tumors | | | | |
NCT00032097: Motexafin Gadolinium in Treating Patients With Glioblastoma Multiforme Who Are Undergoing Radiation Therapy to the Brain |
|
|
| Completed | 1 | | US | motexafin gadolinium, radiation therapy | National Cancer Institute (NCI) | Brain and Central Nervous System Tumors | | | | |
NCT00080054: A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas |
|
|
| Completed | 1 | 24 | US | Motexafin Gadolinium Injection | Pharmacyclics LLC. | Glioma, Glioblastoma, Astrocytoma, Oligodendroglioma, Brain Neoplasm | | | | |
